Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Inhibition of glucagon secretion or antagonism of glucagon receptors has become a potentially effective treatment strategy for T2DM patients (Lund et al., 2014)
Silverman E
Borthakur G, Ishizawa J, DiNardo CD, Kadia TM, Weise K, Allen JE, Oster W, Cortes JE, Kantarjian HM, Andreeff M
That report leveraged data on prospective launches from intelligence and analytics firm Evaluate, which has estimated that the drug could reach $1.3 billion in 2030 sales
H., Baldi, P
US$ 27.30
US$ 26.25
US$ 29.17
US$ 25.98
US$ 21.80
US$ 23.88
US$ 24.25
US$ 23.76
US$ 29.49
